Post-Transplant Maintenance With The Deacetylase Inhibitor Panobinostat In Patients With High-Risk AML Or MDS: Results Of The Phase I Part Of The Panobest Trial

被引：4
|
作者：
Bug, Gesine
Burchert, Andreas
Nicolaus, Kroeger
Huenecke, Sabine
Duenzinger, Ulrich
Wolf, Andrea
Bader, Peter
Serve, Hubert
Ottmann, Oliver G.
机构：
来源：
BLOOD | 2013年 / 122卷 / 21期
关键词：
D O I：
10.1182/blood.V122.21.3315.3315
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3315
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Phase I/II study of the deacetylase inhibitor panobinostat after allogeneic stem cell transplantation in patients with high-risk MDS or AML (PANOBEST trial)
    G Bug
    A Burchert
    E-M Wagner
    N Kröger
    T Berg
    S Güller
    S K Metzelder
    A Wolf
    S Hünecke
    P Bader
    J Schetelig
    H Serve
    O G Ottmann
    [J]. Leukemia, 2017, 31 : 2523 - 2525
  • [2] Phase I/II study of the deacetylase inhibitor panobinostat after allogeneic stem cell transplantation in patients with high-risk MDS or AML (PANOBEST trial)
    Bug, G.
    Burchert, A.
    Wagner, E-M
    Kroeger, N.
    Berg, T.
    Gueller, S.
    Metzelder, S. K.
    Wolf, A.
    Huenecke, S.
    Bader, P.
    Schetelig, J.
    Serve, H.
    Ottmann, O. G.
    [J]. LEUKEMIA, 2017, 31 (11) : 2523 - 2525
  • [3] Phase I/II Study of the Deacetylase Inhibitor Panobinostat As Maintenance Therapy after an Allogeneic Stem Cell Transplantation in Patients with High-Risk MDS or AML: The Panobest-Trial
    Bug, Gesine
    Burchert, Andreas
    Wagner, Eva-Maria
    Kroeger, Nicolaus
    Jedlickova, Zuzana
    Gueller, Saskia
    Metzelder, Stephan
    Wolf, Andrea
    Bader, Peter
    Huenecke, Sabine
    Serve, Hubert
    Ottmann, Oliver G.
    [J]. BLOOD, 2015, 126 (23)
  • [4] Panobinostat as maintenance therapy after allogeneic stem cell transplantation in patients with high-risk MDS or AML: Results from the dose-escalation part of the PANOBEST trial
    Bug, G.
    Burchert, A.
    Wagner, E. M.
    Kroeger, N.
    Jedlickova, Z.
    Gueller, S.
    Wolf, A.
    Huenecke, S.
    Bader, P.
    Serve, H.
    Ottmann, O. G.
    [J]. BONE MARROW TRANSPLANTATION, 2015, 50 : S59 - S59
  • [5] PHASE I/II STUDY OF PANOBINOSTAT FOLLOWING ALLOGENEIC STEM CELL TRANSPLANTATION IN PATIENTS WITH HIGH RISK MDS OR AML: INITIAL RESULTS FROM THE PHASE I PART OF THE PANOBEST TRIAL
    Bug, G.
    Burchert, A.
    Kroeger, N.
    Duenzinger, U.
    Wolf, A.
    Huenecke, S.
    Bader, P.
    Serve, H.
    Ottmann, O.
    [J]. HAEMATOLOGICA, 2013, 98 : 370 - 370
  • [6] Venetoclax Plus Azacitidine Versus Azacitidine Alone As Post-Transplant Maintenance Treatment in High-Risk AML and MDS
    Cao, Yigeng
    Guo, Wenwen
    Zhai, Weihua
    Wei, Jialin
    Ma, Qiaoling
    Yang, Donglin
    Pang, AiMing
    Han, Mingzhe
    Jiang, Erlie
    [J]. BLOOD, 2023, 142
  • [7] Dose-finding trial of azacitidine as post-transplant maintenance for high-risk MDS: a KSGCT prospective study
    Najima, Yuho
    Tachibana, Takayoshi
    Takeda, Yusuke
    Koda, Yuya
    Aoyama, Yasuhisa
    Toya, Takashi
    Igarashi, Aiko
    Tanaka, Masatsugu
    Sakaida, Emiko
    Abe, Ryohei
    Onizuka, Makoto
    Kobayashi, Takeshi
    Doki, Noriko
    Ohashi, Kazuteru
    Kanamori, Heiwa
    Ishizaki, Takuma
    Yokota, Akira
    Morita, Satoshi
    Okamoto, Shinichiro
    Kanda, Yoshinobu
    [J]. ANNALS OF HEMATOLOGY, 2022, 101 (12) : 2719 - 2729
  • [8] Dose-finding trial of azacitidine as post-transplant maintenance for high-risk MDS: a KSGCT prospective study
    Yuho Najima
    Takayoshi Tachibana
    Yusuke Takeda
    Yuya Koda
    Yasuhisa Aoyama
    Takashi Toya
    Aiko Igarashi
    Masatsugu Tanaka
    Emiko Sakaida
    Ryohei Abe
    Makoto Onizuka
    Takeshi Kobayashi
    Noriko Doki
    Kazuteru Ohashi
    Heiwa Kanamori
    Takuma Ishizaki
    Akira Yokota
    Satoshi Morita
    Shinichiro Okamoto
    Yoshinobu Kanda
    [J]. Annals of Hematology, 2022, 101 : 2719 - 2729
  • [9] Novel First-in-Class Drug ONC201 As a Post-Transplant Maintenance for AML and MDS: A Phase I Trial in Progress
    Bhatt, Vijaya Raj
    Wichman, Christopher
    Bouska, Alyssa C.
    Maness, Lori
    Al-Kadhimi, Zaid S.
    Iqbal, Javeed
    Talmadge, James E.
    Gundabolu, Krishna
    [J]. BLOOD, 2022, 140 : 12918 - 12919
  • [10] Trial in Progress: A Phase I Trial of BTX-A51 in Patients with Relapsed or Refractory AML or High-Risk MDS
    Ball, Brian J.
    Stein, Anthony S.
    Borthakur, Gautam
    Murray, Crystal
    Kook, Karin
    Chan, Kyle Wh
    Stein, Eytan M.
    [J]. BLOOD, 2020, 136
12345